+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Oral sildenafil is an effective specific pulmonary vasodilator in patients with pulmonary arterial hypertension



Oral sildenafil is an effective specific pulmonary vasodilator in patients with pulmonary arterial hypertension



Acc Current Journal Review 11(6): 20-0




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063102317

Download citation: RISBibTeXText

DOI: 10.1016/s1062-1458(02)00907-8


Related references

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension. Journal of the American College of Cardiology 39(5 Supplement A): 224A, March 6, 2002

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide. Circulation 105(20): 2398-2403, May 21, 2002

Survival of patients with pulmonary arterial hypertension after the advent of specific pulmonary vasodilator therapies. Revista Medica de Chile 144(7): 829-836, 2017

Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy. Mayo Clinic Proceedings 78(10): 1207-1213, 2003

Sildenafil is more selective pulmonary vasodilator than prostaglandin E1 in patients with pulmonary hypertension due to heart failure. Physiological Research 60(2): 303-308, 2011

Sildenafil is a pulmonary vasodilator which augments and prolongs vasodilatation by inhaled nitric oxide in patients with pulmonary hypertension. Circulation 100(18 SUPPL ): I 240, Nov 2, 1999

Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH). Journal of Controlled Release 250: 96-106, 2017

Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension. Pulmonary Circulation 5(2): 305-312, 2015

Oral sildenafil therapy for Chinese patients with pulmonary arterial hypertension: a multicenter study. Journal of Clinical Pharmacology 52(3): 425-431, 2012

Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertension. Journal of Cardiovascular Pharmacology 45(4): 286-289, 2005

Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension. Journal of Heart and Lung Transplantation 26(11): 1079-1083, 2007

Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources. Cardiology in the Young 17(1): 72-77, 2006

Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest 123(4): 1293-1295, 2003

Beneficial effect of oral sildenafil on cardiac function and ventricular remodelling in patients with pulmonary arterial hypertension. Circulation 108(17 Supplement): IV-643-IV-644, October 28, 2003

Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation. Transplantation Proceedings 45(6): 2347-2350, 2014